NIH Clinical Trials Contacts
The High-Risk, High-Reward Research program welcomes any project relevant to the NIH mission, including clinical trials. Though technical and conceptual risks are expected in highly innovative projects, clinical research must also contend with potential risks to human subjects. Because awards are administered by the most topic-relevant NIH Institute or Center (IC), applicants proposing NIH-defined clinical trials should contact program staff at the appropriate IC to ensure their applications conform to NIH and IC-specific policies for clinical trials.
IC | Specific Instructions | Contact |
---|---|---|
NCATS | The National Center for Advancing Translational Sciences (NCATS) strives to develop innovations in order to reduce, remove or bypass costly and time-consuming bottlenecks in the translational research pipeline to speed the delivery of new drugs, diagnostics and medical devices to patients. Translational science is the field of investigation focused on understanding the scientific and operational principles underlying each step of the translational process. Translating biomedical discoveries into clinical applications is essential to improving human health. It is also a complex process with high costs and substantial failure rates. NCATS is interested in supporting clinical trials that aim to improve this translational process. Some examples of research that could be supported through this FOA include but are not limited to
|
Jane C. Atkinson, DDS Phone: (301) 827-6031 Email: jatkinso@nih.gov |
NCCIH | Contact by research area | |
NCI | William Timmer, PhD |
|
NEI | NEI will only accept “Mechanistic” or “Minimal Risk” clinical trials under this funding opportunity. A mechanistic trial is defined as "a study designed to understand a biological of behavioral process, the pathophysiology of a disease, or the mechanism of action of an intervention." "Minimal risk" means that the probability and magnitude of harm or discomfort anticipated in the research are not greater in and of themselves than those ordinarily encountered in daily life or during the performance of routine physical or psychological examinations or tests. | Donald Everett, MA Phone: (301) 451-2020 Email: dfe@nei.nih.gov |
NHGRI | Simona Volpi, PharmD, PhD Phone: (301) 480-3480 Email: volpis@mail.nih.gov |
|
NHLBI | Gail D. Pearson, MD, ScD, FACC, FAHA Phone: (301) 435-0477 Email: pearsong@nhlbi.nih.gov |
|
NIA |
|
Sergei Romashkan, MD, PhD Phone: (301) 435-3047 Email: romashks@nia.nih.gov |
NIAID | Gregory Deye, MD Phone: (240) 292-4199 Email: gregory.deye@nih.gov |
|
NIAMS | Contact by research area | |
NICHD | Caroline Signore, MD, MPH Phone: (301) 496-5577 Email: signorec@mail.nih.gov |
|
NIDA | Katia Howlett, PhD, MPP, MBA Phone: (301) 443-4877 Email: delrahimhowlekn@mail.nih.gov |
|
NIDCD | Steven Hirschfeld, MD, PhD Phone: (301) 496-5061 Email: hirschfs@mail.nih.gov Trinh Ly, MD Phone: (301) 435-4085 Email: trinh.ly@nih.gov |
|
NIDCR | Lillian Shum, PhD Phone: (301) 594-0618 Email: shuml@mail.nih.gov |
|
NIDDK | Policies for clinical researchers | Barbara Linder, MD, PhD Phone: (301) 594-0021 Email: linderb@mail.nih.gov |
NIGMS | NIGMS supports basic biomedical research that contributes to the understanding of fundamental cellular and physiological principles. General areas of interest include cell biology, biophysics, genetics, developmental biology, pharmacology, physiology, biological chemistry, biomedical technology, bioinformatics and computational biology. The Institute also supports research in certain clinical areas, primarily those that affect multiple organ systems. Additional information is available on the NIGMS website about research interests (including staff contact information) and clinical studies and trials. | Sarah Dunsmore, PhD Phone: (301) 594-3827 Email: dunsmores@mail.nih.gov |
NIMH | NOT-MH-18-004: NIMH Only Accepts Clinical Trial Applications Proposing Mechanistic Studies for Clinical Trial Parent R01 and R21 Announcements | Contact by research area |
NINDS | Contact by research area |
This page last reviewed on June 16, 2020